Drugs / amoxicillin/clavulanic acid
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00716183 Comparator | Jul 2008 | mastitis | Universidad Complutense de Madrid | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amoxicillin/clavulanic acid | “Use of amoxicillin, cloxacillin or amoxicillin/clavulanic acid(500-750 mg), orally, every 8-12 h, for 2-3 weeks” NCT00716183 ↗ |
| Modality | Other / unclassified | “Beta-lactam antibiotic” NCT00716183 ↗ |
| Route | Oral | “orally” NCT00716183 ↗ |